blackandgay676 t1_japvmhj wrote
The cost reduction part is highly dependent on the number of generic makers who want to get in.
I work in HIV prevention and the first generic of Truvada went from 2000 for brand name to ~1400 for generic because for the first 6 months there was only one generic drug maker. After those 6 months were up the price plummeted and I think now list price for it is anywhere from 30-100 bucks.
[deleted] t1_japxich wrote
[removed]
[deleted] t1_jaq20r7 wrote
[removed]
[deleted] t1_jaq945h wrote
[removed]
[deleted] t1_japytfj wrote
[removed]
[deleted] t1_japy6od wrote
[removed]
[deleted] t1_japyel6 wrote
[removed]
[deleted] t1_jaq0hys wrote
[removed]
[deleted] t1_jaq0izh wrote
[removed]
[deleted] t1_jaq0qdd wrote
[removed]
[deleted] t1_jaq6amc wrote
[removed]
[deleted] t1_jaq6yek wrote
[removed]
[deleted] t1_jaq74my wrote
[removed]
[deleted] t1_jaqb8j5 wrote
[removed]
[deleted] t1_jaqcppd wrote
[removed]
SNRatio t1_jaq5cro wrote
A study on competition a while ago found that the first competitor usually didn't have that big of an impact on price. The second competitor is what moves the needle.
somdude04 t1_jaq6tvs wrote
That's because we have a rule in place to give that first generic a 180 say exclusivity benefit because they were first, where they still price gouge because the only price they need to beat is the name brand one, and only barely.
im_thatoneguy t1_jaq9ync wrote
I wonder how close to repaying their entire capex they get in those first 180 days.
[deleted] t1_jaqavzp wrote
[removed]
Viewing a single comment thread. View all comments